Loracarbef versus phenoxymethylpenicillin in the treatment of recurrent streptococcal pharyngotonsillitis

Scandinavian Journal of Infectious Diseases

Volumn 29, Issue 2, 1997, Pages 141-145

  Roos, Kristian ^a,b   Larsson, Peter ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b Capio AB   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAMASE; LORACARBEF; PENICILLIN V;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; HUMAN; MAJOR CLINICAL STUDY; MOUTH FLORA; MULTICENTER STUDY; PHARYNGITIS; RANDOMIZED CONTROLLED TRIAL; RECURRENT INFECTION; STREPTOCOCCUS; STREPTOCOCCUS GROUP A; TONSILLITIS;

EID: 0030905626     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365549709035874     Document Type: Article

References (20)

1. Roos K, Holm SE, Ekedahl C. Treatment failure in acute streptococcal tonsillitis in children over age of ten and in adults. Clinical and therapeutical aspects. Scand J Infect Dis 17: 357-365, 1985.
2. Strömberg A, Schwan A, Cars O. Five versus ten days treatment of group A streptococcal pharyngotonsillitis: a randomized controlled clinical trial with phenoxymethylpenicillin and cefadroxil. Scand J Infect Dis 20: 37-46, 1988.
3. Schwartz RH, Wientzen RL, Pedreira F, Feroli E, Mella G, Guandolo V. Penicillin V for group A streptococcal pharyngotonsillitis. JAMA 246: 1790-1795, 1981.
4. Roos K, Holm SE, Grahn E, Lind L. α-streptococci as supplementary treatment of recurrent streptococcal tonsillitis. A randomized placebo controlled study. Scand J Infect Dis 25: 31-35, 1993.
5. Roos K, Grahn E, Holm SE. Evaluation of β-lactamase activity and microbial interference in treatment failures of acute streptococcal tonsillitis. Scand J Infect Dis 18: 13-19, 1986.
6. Brook I, Yocum P, Calhoun L. β-Laclamase producing Bacteroides species recovered from children. Possible clue to failure of penicillin treatment. Lancet 1: 332, 1981.
7. Brook I. The role of β-lactamase producing bacteria in the persistence of streptococcal tonsillar infection. Rev Infect Dis 6: 601-607, 1984.
8. Grahn E, Holm SE, Roos K. Penicillin tolerance in β-streptococci isolated from patients with tonsillitis. Scand J Infect Dis 19: 421-426, 1987.
9. Grahn E, Holm SE. Bacterial interference in the throat flora during a streptococcal tonsillitis outbreak in an apartment house area. Zbl Bakt Hyg A 256: 72 79, 1983.
10. Pichichero M. The rising incidence of penicillin treatment failures in group A sreptococcal tonsillopharyngitis: an emerging role for the cephalosporins? Scand J Infect Dis 10: 50-55, 1991.
11. Olsson-Liljequist B, Burman L, Kallings I and The Swedish Respiratory Tract Study Group. Antibiotic susceptibility of upper respiratory tract pathogens in Sweden: A seven year follow-up study including loracarbef. Scand J Infect Dis 24: 485-493, 1992.
12. McCarty J. Loracarbef versus Penicillin VK in the treatment of streptococcal pharyngitis and tonsillitis in an adult population. Am J Med 92 Suppl 6A: 74-79, 1992.
13. Disney FA, Hanfling MJ, Hausinger S A. Loracarbef (LY163892) vs. penicillin VK in the treatment of streptococcal pharyngitis and tonsillitis. Pediatr Infect Dis J 11:S20-S26, 1992.
14. Facklam RR, Washington JA. Streptococcus and related catalase-negative Gram-positive cocci. In: Balows A, Hausler WJ, Herrman KL, Isenberg HD, Shadomy HJ, eds. Manual of clinical microbiology, 5th ed. Washington, DC: American Society for Microbiology, 238-257, 1991.
15. Maxted W, Widdowson JP. The protein antigens of group A streptococci: In Wannamaker LW, Matsen JM, eds. Streptococci and streptococcal diseases. New York: Academic Press, 251-264, 1972.
16. Holm S, Henning C, Grahn E, Lomberg H, Staley H. Is penicillin the appropriate treatment for recurrent tonsillopharyngitis? Results from a comparative randomized blind study of cefuroxime axetil and phenoxymethylpenicillin in children. Scand J Infect Dis 27: 221-228, 1995.
17. Orrling A, Stjernqvist-Desatnik A, Schalén C, Kamme C. Clindamycin in persisting pharyngotonsillitis after penicillin treatment. Scand J Infect Dis 20: 535-541, 1994.
18. Brook I. Treatment of patients with acute recurrent tonsillitis due to group A β-haemolytic streptococci: a prospective randomized study comparing penicillin and amoxycillin/clavulanic potassium. J Antimicrob Chemother 24: 227-233, 1989.
19. Nord CE, Grahnen A, Eckernäs S-Å. Effect of loracarbef on the normal oropharyngeal and intestinal microflora. Scand J Infect Dis 23: 255-260, 1991.
20. Neu H. The crisis in antibiotic resistance. Science 257: 1064-1073, 1992.